FRAMINGHAM, Mass. and SYDNEY, Aug. 11 /PRNewswire-FirstCall/ -- HeartWare
International, Inc. (Nasdaq: HTWR, ASX: HIN) today announced that it is
scheduled to make an investor presentation at the Canaccord Adams 29th Annual
Global Growth Conference at 2:00 pm EDT on Thursday, August 13, 2009. The
conference will be held at the InterContinental Boston Hotel, August 11-13,
A live webcast of the Company's presentation at the conference will be
available via a link provided at www.heartware.com. An archived replay of the
presentation will be available shortly after the presentation time for a
period of 90 days.
About HeartWare International, Inc.
HeartWare International, Inc. develops and manufactures miniaturized
implantable heart pumps, or Left Ventricular Assist Devices (LVADs), to treat
patients suffering from advanced heart failure. The HeartWare Ventricular
Assist System features the HVAD(TM) pump, the only full-output pump designed
to be implanted next to the heart, avoiding the abdominal surgery generally
required to implant competing devices. HeartWare has completed an
international clinical trial for the device involving five investigational
centres in Europe and Australia. The device is currently the subject of a
150-patient clinical trial in the United States for a Bridge-to-Transplant
SOURCE HeartWare International, Inc.
For further information:
US Investor Relations
Allen & Caron Inc
Tel: +1 949 474 4300